Literature DB >> 9626775

Severity of cognitive impairment in juvenile and late-onset Huntington disease.

E Gómez-Tortosa1, A del Barrio, P J García Ruiz, R S Pernaute, J Benítez, A Barroso, F J Jiménez, J García Yébenes.   

Abstract

OBJECTIVES: To compare the severity of cognitive impairment among groups of patients with different age ranges at the onset of Huntington disease (HD) and to evaluate the variable influence of motor and cognitive deficits on functional disability across different ages at the onset of HD.
DESIGN: Cross-sectional multidisciplinary evaluation of patients referred to our institution for care related to a possible diagnosis of HD.
SETTING: The Huntington disease program in the Departments of Neurology and Genetics at the Fundación Jimenez Diaz, Madrid, Spain. PARTICIPANTS: Seventy-one patients with Huntington disease were classified into 3 groups depending on age at onset of motor symptoms: juvenile onset, 25 years of age or younger (group 1, n = 15); adult onset, from 26 to 50 years (group 2, n = 43); and late onset, 51 years or older (group 3, n = 13). Age- and education-matched controls (n=50) were included to compare cognitive performance with patients in groups 1 and 3. MEASURES: Cognitive evaluation encompassed a wide neuropsychological battery to assess global cognitive functioning and visuospatial, prefrontal, and memory functions. Clinical data included motor and functional variables measured by using the Unified Huntington's Disease Rating Scale. Genetic analysis determined the number of CAG trinucleotide repeats.
RESULTS: Patients in group 1 scored 2.9 points and patients in group 3 scored 4.2 points below their respective controls on the Mini-Mental State Examination. Patients in groups 1 and 3 were similarly impaired in verbal memory. Visual function was much more impaired in patients in group 3, and prefrontal functions were slightly worse in patients in group 1. Cognitive scores were correlated only with time of evolution for patients in group 2. Functional scores were not significantly different among the 3 groups, but 11 (85%) of the patients in group 3 were in stage I or II vs 10 (67%) of the patients in group 1. Total functional capacity correlated better with the Mini-Mental State Examination score for patients in group 3 and with motor deficits (akinesia) and prefrontal dysfunction for patients in group 1. The mean+/-SD CAG repeat length decreased from 59.9+/-12.6 for patients in group 1 to 46.2+/-3.5 for patients in group 2 and 41.7+/-2.6 for patients in group 3. Longer CAG repeats in the HD study population correlated with akinetic features but not with cognitive performance.
CONCLUSIONS: Despite the much greater genetic defect, cognitive status is slightly better preserved in patients with juvenile-onset HD. Cognitive impairment in patients with juvenile- and late-onset HD differs in the severity of visual and prefrontal deficits. Functional disability in patients with late-onset HD depends more on global cognitive status, while in patients with juvenile-onset HD, it is conditioned more by motor deficits and prefrontal dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9626775     DOI: 10.1001/archneur.55.6.835

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Authors:  Abderrahmane Hedjoudje; Gaël Nicolas; Alice Goldenberg; Catherine Vanhulle; Clémentine Dumant-Forrest; Guillaume Deverrière; Pauline Treguier; Isabelle Michelet; Lucie Guyant-Maréchal; Didier Devys; Emmanuel Gerardin; Jean-Nicolas Dacher; Pierre-Hugues Vivier
Journal:  Pediatr Radiol       Date:  2018-06-20

2.  Structure of Membrane-Bound Huntingtin Exon 1 Reveals Membrane Interaction and Aggregation Mechanisms.

Authors:  Meixin Tao; Nitin K Pandey; Ryan Barnes; Songi Han; Ralf Langen
Journal:  Structure       Date:  2019-08-26       Impact factor: 5.006

3.  Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.

Authors:  Martina Petracca; Sonia Di Tella; Marcella Solito; Paola Zinzi; Maria Rita Lo Monaco; Giulia Di Lazzaro; Paolo Calabresi; Maria Caterina Silveri; Anna Rita Bentivoglio
Journal:  Eur J Neurol       Date:  2022-04-17       Impact factor: 6.288

4.  The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.

Authors:  Oliver Quarrell; Kirsty L O'Donovan; Oliver Bandmann; Mark Strong
Journal:  PLoS Curr       Date:  2012-07-20

Review 5.  What do we know about Late Onset Huntington's Disease?

Authors:  Sai S Chaganti; Elizabeth A McCusker; Clement T Loy
Journal:  J Huntingtons Dis       Date:  2017

6.  Influence of Age of Onset on Huntington's Disease Phenotype.

Authors:  Lauren Kwa; Danielle Larson; Chen Yeh; Danny Bega
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-07-09

7.  Late-onset Huntington's disease with 40-42 CAG expansion.

Authors:  Elisa Capiluppi; Luca Romano; Paola Rebora; Lorenzo Nanetti; Anna Castaldo; Cinzia Gellera; Caterina Mariotti; Antonella Macerollo; M Giuliana Cislaghi
Journal:  Neurol Sci       Date:  2019-12-09       Impact factor: 3.307

8.  "Spazio Huntington": Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats.

Authors:  Federica Graziola; Sabrina Maffi; Melissa Grasso; Giacomo Garone; Simone Migliore; Eugenia Scaricamazza; Consuelo Ceccarelli; Melissa Casella; Ludovica Busi; Barbara D'Alessio; Alessandro De Luca; Giovanna Stefania Colafati; Umberto Sabatini; Alessandro Capuano; Ferdinando Squitieri
Journal:  J Pers Med       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.